Transgenomic Secures Additional Financing

Transgenomic has concluded negotiations with Laurus Master Fund aimed at firming up its financing for ongoing operations. Laurus has agreed to extend, until March 31, 2006, a previously issued waiver to the borrowing base limitation contained in its revolving facility with the corporation, thereby making the full $7.5 million revolving facility available throughout 2005.

PharmaLive (http://www.pharmalive.com/News/index.cfm?articleid=222365&categoryid=15)